The MITO8-ENGOT OV1 phase 3 international multicenter randomized study testing the effect on survival of prolonging platinum-free interval (PFI) in patients with ovarian cancer (OC) recurring between 6 and 12 months after previous platinum based chemotherapy - Pignata, S; Scambia, G; Raspagliesi, F (A collaboration of MITO, MaNGO, AGO, BGOG, ENGOT, and GCIG. J Clin Oncol, 2016)
(suppl; abstr 5505)